申请人:Cheng Xue-Min
公开号:US20070088069A1
公开(公告)日:2007-04-19
Novel imidazole compounds and pharmaceutical compositions are described, as are methods of using such compounds, alone or in combination with another pharmaceutically active agent, to treat subjects, including humans, suffering from hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, and atherosclerosis.
描述了新型咪唑化合物和药物组合物,以及使用这些化合物的方法,单独或与另一种药用活性剂结合,用于治疗患有高脂血症、高胆固醇血症、高甘油三酯血症和动脉粥样硬化的受试者,包括人类。